Jeff Kindler is retiring after four-and-a-half years as CEO of Pfizer, reports The Wall Street Journal. In a statement, Kindler said that his time there was "extremely exciting and rewarding" though also "extremely demanding" on him personally.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.